Related Experiment Video
Updated: Jul 28, 2026
20:23
A Lectin HPLC Method to Enrich Selectively-glycosylated Peptides from Complex Biological Samples
Published on: October 1, 2009
16.1K
Fucose-binding lectins: purification, characterization and potential biomedical applications.
Ramanathan Nivetha1, Mani Meenakumari1, Ayikkara Peroor Mahi Dev1
1Department of Zoology, University of Madras, Guindy Campus, Chennai, 600 025, India.
Molecular Biology Reports
|November 7, 2023
Summary
Fucose-binding lectins (FBLs) are significant in biomedical research for their carbohydrate-binding properties. This review details their purification, characterization, and potential as anti-cancer agents and diagnostic markers.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Lectins are proteins with specific carbohydrate-binding capabilities, crucial in biological recognition.
- Fucose-binding lectins (FBLs) are a significant class found across diverse taxa, known for binding fucose.
- Their purification began in 1967, with numerous FBLs subsequently isolated and characterized from various sources.
Purpose of the Study:
- To review the occurrence and purification strategies of FBLs.
- To highlight the molecular and functional characterization of FBLs.
- To explore the potential applications of FBLs in biomedical research.
Main Methods:
- Literature review focusing on FBL purification and characterization.
- Analysis of purification strategies, including affinity chromatography using fucose derivatives.
- Compilation of data on molecular structures and functional properties of various FBLs.
Main Results:
- FBLs are widely distributed in plant and animal kingdoms.
- Diverse purification techniques have been employed, often involving affinity matrices.
- Characterized FBLs exhibit varied structures and functions.
Conclusions:
- FBLs possess unique abilities to bind fucose-containing glycans.
- These lectins show promise as anti-cancer agents, diagnostic markers, and immune cell mitogens.
- Further exploration is needed to fully harness FBLs as biomedical tools.
